A detailed history of New Edge Advisors, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 50 shares of IDYA stock, worth $1,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$1,525
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$34.37 - $43.46 $1,718 - $2,173
50 New
50 $1,000
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $1,331 - $1,671
92 New
92 $1,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.47B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.